跳至主要内容
临床试验/NCT05716750
NCT05716750尚未招募不适用

Serum Prolidase Activity and the Role of Leptin in Osteomalacia

TUĞBA ŞAHBAZ0 个研究点目标入组 38 人开始时间: 2023年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
38
主要终点
Serum Prolidase activity

研究概览

简要总结

Evaluation of the change of serum Prolidase and Leptin values in the diagnosis and follow-up of osteomalacia and its clinical usability

详细描述

Osteomalacia describes a bone disorder in adults that is usually caused by long-term vitamin D deficiency. Osteomalacia, a metabolic bone disease characterized by impaired mineralization of the bone matrix.Not a single laboratory finding is specific to osteomalacia.The relationship between collagen and prolidase activity has been observed during fibrotic processes, where an increase in prolidase activity is accompanied by an increase in tissue collagen deposition. It has also been suggested that serum activity is increased in metabolic bone diseases.Leptin is a 16 kDa peptide hormone. It is a member of the long chain helical cytokine family, which is mainly produced by fat cells and proportional to the size of the stored fat. Leptin affects bone remodeling by reducing the activity of osteoclasts and thus participates in the pathogenesis of osteoporosis. In the light of these studies, the investigators planned our study according to the clinical significance of serum prolidase activity in osteomalacia and the place of leptin in osteomalacia.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Among the patients who applied to the outpatient clinic, those with clinical complaints of osteomalacia (diffuse pain, fatigue, rapid fatigue, proximal extremity weakness, etc.)
  • 25 0H vit. D level of 10ng/ml and below

排除标准

  • Other metabolic and endocrine bone diseases (secondary osteoporosis, paget hast, osteogenesis imperfecta, osteomyelitis etc.)
  • Patients who have previously received treatment for low vitamin d
  • Those with low vitamin D levels due to liver or kidney failure
  • Those who receive treatment for tumor

结局指标

主要结局

Serum Prolidase activity

时间窗: 8 weeks

Prolidase activity

Serum Leptin

时间窗: 8 weeks

Leptin

次要结局

未报告次要终点

研究者

发起方
TUĞBA ŞAHBAZ
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

TUĞBA ŞAHBAZ

assist. prof. dr

University of Beykent

相似试验